4//SEC Filing
AzurRx BioPharma, Inc. 4
Accession 0001415889-17-001081
$GRDXCIK 0001604191operating
Filed
Jul 2, 8:00 PM ET
Accepted
Jul 3, 4:57 PM ET
Size
7.8 KB
Accession
0001415889-17-001081
Insider Transaction Report
Form 4
Pelican Partners LLC
10% Owner
Transactions
- Sale
Common Stock
2017-06-30$3.50/sh−60,000$210,000→ 1,727,796 total - Sale
Common Stock
2017-06-30$3.00/sh−100,000$300,000→ 1,787,796 total
BALK MATTHEW
10% Owner
Transactions
- Sale
Common Stock
2017-06-30$3.50/sh−60,000$210,000→ 1,727,796 total - Sale
Common Stock
2017-06-30$3.00/sh−100,000$300,000→ 1,787,796 total
Footnotes (1)
- [F1]Securities were sold in private, negotiated transactions. The purchasers agreed to not sell the securities purchased for a period of 120 days, resulting in a lock-up during such period.
Documents
Issuer
AzurRx BioPharma, Inc.
CIK 0001604191
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001604191
Filing Metadata
- Form type
- 4
- Filed
- Jul 2, 8:00 PM ET
- Accepted
- Jul 3, 4:57 PM ET
- Size
- 7.8 KB